PDF herunterladen
CC BY-NC-ND 4.0 · International Journal of Epilepsy 2017; 04(02): 174-180
DOI: 10.1016/j.ijep.2017.10.002
Case report
Thieme Medical and Scientific Publishers Private Ltd.

Disseminated cysticercosis and role of spin echo short tau inversion recovery sequence imaging: Case based review

Lakshmi Narasimhan Ranganathan
a   Institute of Neurology, Madras Medical College, Chennai, India
,
Venkatraman Karthikeayan
a   Institute of Neurology, Madras Medical College, Chennai, India
,
Arun Shivaraman MM
a   Institute of Neurology, Madras Medical College, Chennai, India
,
Guhan R.
a   Institute of Neurology, Madras Medical College, Chennai, India
,
Venkateswaran KJ
a   Institute of Neurology, Madras Medical College, Chennai, India
,
Thamil Pavai N
a   Institute of Neurology, Madras Medical College, Chennai, India
,
Manmohan Mehndiratta
b   Janakpuri Super Specialty Hospital, Delhi, India
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received: 24. Mai 2017

Accepted: 12. Oktober 2017

Publikationsdatum:
10. Mai 2018 (online)

   Lizenzen und Reprints
1

Introduction

Disseminated Cysticercosis is a systemic parasitic infection by the larval stage of the pork tape worm Taenia solium. It presents predominantly with neurological and extra neurological symptoms. Neurocysticercosis is involvement of the central nervous system by the encysted larval stage, ‘cysticercus cellulosae’ of the pork tapeworm Taenia solium. Neurocysticercosis is widely prevalent in the tropic. It is one of the commonest causes of adult onset seizure in tropics. In this report we discuss two cases of disseminated cysticercosis and the current concepts in the imaging and management of disseminated cysticercosis.

 

  • References

  • 1 Garg RK. Diagnostic criteria for neurocysticercosis: some modifications are needed for Indian patients. Neurol Ind 52 2004; 171-177
    PubMedGoogle Scholar
  • 2 Jawale R, Duberkar D. Disseminated cysticercosis. Neurology 84 January (3) 2015; 327
    CrossrefPubMedGoogle Scholar
  • 3 Mahajan RC. Geographical distribution of human cysticercosis. Flisser A, Willms K, Laclette TP, Larralde C, Ridaura C, NBeltram F. Cysticercosis: Present State of Knowledge and Perspective. 1982. Academic Press; New York: 39-46
    Google Scholar
  • 4 Chopra JS, Kaur U, Mahajan RC. Cysticercosis and epilepsy: a clinicaland serological study. Trans R Soc Trop Med Hyg 75 1981; 518-520
    CrossrefPubMedGoogle Scholar
  • 5 Wadia Noshir, Desai Shrinivas, Bhatt Mohit. Disseminated cysticercosis. Brain 111 (03) 1988; 597-614
    CrossrefPubMedGoogle Scholar
  • 6 Del Brutto OH, Rajshekhar V, White Jr AC. et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 57 2001; 177-183
    CrossrefPubMedGoogle Scholar
  • 7 Nash TheodoreE, Patronas NicholasJ. Edema associated with calcified lesions in neurocysticercosis. Neurology 53 (04) 1999; 777
    CrossrefPubMedGoogle Scholar
  • 8 Garcı'a HéctorH, Del Brutto OscarH. Imaging findings in neurocysticercosis. Acta Trop 87 (01) 2003; 71-78
    CrossrefPubMedGoogle Scholar
  • 9 Lerner A, Shiroishi MS, Zee CS, Law M, Go JL. Imaging of neurocysticercosis. Neuroimaging Clin N Am 22 November (4) 2012; 659-676
    CrossrefPubMedGoogle Scholar
  • 10 Pandit S, Lin A, Gahbauer H. et al. MR spectroscopy in neurocysticercosis. J Comput Assist Tomogr 25 (06) 2001; 950-952
    CrossrefPubMedGoogle Scholar
  • 11 Chavhan GovindB, Babyn PaulS. Whole-body MR imaging in children: principles, technique, current applications, and future directions. Radiographics 31 (06) 2011; 1757-1772
    CrossrefPubMedGoogle Scholar
  • 12 Garg M, Chawla S, Prasad KN. et al. Differentiation of hydatid cyst from cysticercus cyst by proton MR spectroscopy. NMR Biomed 15 (05) 2002; 320-326
    CrossrefPubMedGoogle Scholar
  • 13 Kellenberger CJ, Epelman M, Miller SF. et al. Fast STIR whole-body MR imaging in children 1. Radiographics 24 (05) 2004; 1317-1330
    CrossrefPubMedGoogle Scholar
  • 14 Udare A, Juvekar S, Medhi S. et al. Disseminated cysticercosis: role of whole body Magnetic Resonance Imaging. Ann Parasitol 62 (02) 2016; 149
    PubMedGoogle Scholar
  • 15 Garcia HH, Del Brutto OH. Taenia solium cysticercosis. Infect Dis Clin North Am 14 March (1) 2000; 97-119
    CrossrefPubMedGoogle Scholar
  • 16 Abba K, Ramaratnam S, Ranganathan LN. Anthelmintics for people with neurocysticercosis. Cochrane Database Syst Rev. Jan (3) 2010
    PubMedGoogle Scholar
  • 17 Garcia HH, Pretell EJ, Gilman RH. et al. Cysticercosis Working Group in PeruA trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 350 2004; 249-258
    CrossrefPubMedGoogle Scholar
  • 18 Alarcon F, Escalante L, Duenas G, Montalvo M, Roman M. Neurocysticercosis: short course of treatment with albendazole. Arch Neurol 46 (11) 1989; 1231-1236
    CrossrefPubMedGoogle Scholar
  • 19 Alarcon F, Duenas G, Diaz M, Cevallos N, Estrada G. Short course of albendazole therapy for neurocysticercosis: a prospective randomized trial comparing three days, eight days and the control group without albendazole. Rev Ecuat Neurol 10 2001; 1-2
    PubMedGoogle Scholar
  • 20 Carpio A, Kelvin EA, Bagiella E. et al. Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry 79 2008; 1050-1055
    CrossrefPubMedGoogle Scholar
  • 21 Cruz I, Cruz ME, Carrasco F, Horton J. Neurocysticercosis: optimal dose treatment with albendazole. J Neurol Sci 133 (01) (02) 1995; 152-154
    CrossrefPubMedGoogle Scholar
  • 22 Del Brutto OH, Campos X, Sanchez J, Mosquera A. Single-day praziquantel versus 1-week albendazole for neurocysticercosis. Neurology 23 (52) 1999; 1079-1081
    PubMedGoogle Scholar
  • 23 Garcia H, Gilman R, Catacora M. et al. Serologic evolution of neurocysticercosis patients after antiparasitic therapy. J Infect Dis 175 1997; 486-489
    CrossrefPubMedGoogle Scholar
  • 24 Garcia HH, Pretell EJ, Gilman RH. et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 350 (03) 2004; 249-258
    CrossrefPubMedGoogle Scholar
  • 25 Singhi P, Jain V, Khandelwal N. Corticosteroids versus albendazole for treatment of single small enhancing computed tomographic lesions in children with neurocysticercosis. J Child Neurol 19 (05) 2004; 323-327
    CrossrefPubMedGoogle Scholar
  • 26 Sotelo J, Escobedo F, Penagos P. Albendazole vs praziquantel for therapy for neurocysticercosis: a controlled trial. Arch Neurol 45 (05) 1988; 532-534
    CrossrefPubMedGoogle Scholar
  • 27 Sotelo J, Del Brutto OH, Penagos P. et al. Comparison of therapeutic regimen of anticystercal drugs for parenchymal brain cysticercosis. J Neurol 237 1990; 69-72
    CrossrefPubMedGoogle Scholar
  • 28 Garcia HH, Pretell EJ, Gilman RH. et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 350 2004; 249
    CrossrefPubMedGoogle Scholar
  • 29 Del Brutto OH. Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis. Neurology 44 1994; 1706
    CrossrefPubMedGoogle Scholar
  • 30 Carpio A, Hauser WA. Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology 59 2002; 1730
    CrossrefPubMedGoogle Scholar
  • 31 Rajshekhar V, Jeyaseelan L. Seizure outcome in patients with a solitary cerebral cysticercus granuloma. Neurology 62 2004; 2236
    CrossrefPubMedGoogle Scholar
  • 32 Verma A, Misra S. Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurol Scand 113 2006; 174
    CrossrefPubMedGoogle Scholar
  • 33 Nash TE, Pretell EJ, Lescano AG. et al. Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol 7 2008; 1099
    CrossrefPubMedGoogle Scholar
  • 34 Mall RK, Agarwal A, Garg RK. et al. Short course of prednisolone in Indian patients with solitary cysticercus granuloma and new-onset seizures. Epilepsia 44 2003; 1397
    CrossrefPubMedGoogle Scholar
  • 35 Nash TE, Singh G, White AC. et al. Treatment of neurocysticercosis: current status and future research needs. Neurology 67 2006; 1120
    PubMedGoogle Scholar
  • 36 Prakash S, Garg RK, Kar AM. et al. Intravenous methyl prednisolone in patients with solitary cysticercus granuloma: a random evaluation. Seizure 15 2006; 328
    CrossrefPubMedGoogle Scholar
  • 37 Garg RK, Potluri N, Kar AM. et al. Short course of prednisolone in patients with solitary cysticercus granuloma: a double blind placebo controlled study. J Infect 53 2006; 65
    CrossrefPubMedGoogle Scholar
  • 38 Kishore D, Misra S. Short course of oral prednisolone on disappearance of lesion and seizure recurrence in patients of solitary cysticercal granuloma with single small enhancing CT lesion: an open label randomized prospective study. J Assoc Physicians India 55 2007; 419
    PubMedGoogle Scholar